Human herpesviruses 6 and 7: Identification of newly recognized viral pathogens and their association with human disease

Pediatric Infectious Disease Journal

Volumn 17, Issue 1, 1998, Pages 59-68

  Kimberlin, David W ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE   (United States)

Author keywords

Exanthem subitum; Human herpesvirus 6; Human herpesvirus 7; Roseola

Indexed keywords

BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS CHARACTERIZATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0031884417     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199801000-00013     Document Type: Review

References (151)

1. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
2. Josephs SF, Salahuddin SZ, Ablashi DV, Schachter F, Wong-Staal F, Gallo RC. Genomic analysis of the human B-lymphotropic virus (HBLV). Science 1986;234:601-3.
3. + T cells. Proc Natl Acad Sci USA 1990;87:748-52.
4. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
5. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065-7.
6. Ablashi D, Agut H, Berneman Z, et al. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 1993;129:363-6.
7. Downing RG, Sewankambo N, Serwadda D, et al. Isolation of human lymphotropic herpesviruses from Uganda. Lancet 1987;2:390.
8. Lopez C, Pellett P, Stewart J, et al. Characteristics of human herpesvirus-6. J Infect Dis 1988;157:1271-3.
9. Biberfeld P, Kramarsky B, Salahuddin SZ, Gallo RC. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. J Natl Cancer Inst 1987; 79:933-41.
10. Berneman ZN, Ablashi DV, Li G, et al. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci USA 1992;89:10552-6.
11. Wyatt LS, Rodriguez WJ, Balachandran N, Frenkel N. Human herpesvirus 7: antigenic properties and prevalence in children and adults. J Virol 1991;65:6260-5.
12. Clark DA, Freeland ML, Mackie LK, Jarrett RF, Onions DE. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis 1993;168:251-2.
13. Lusso P, Markham PD, Tschachler E, et al. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 1988;167:1659-70.
14. Takahashi K, Sonoda S, Higashi K, et al. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 1989;63:3161-3.
15. Lusso P, Gallo RC, DeRocco SE, Markham PD. CD4 is not the membrane receptor for HHV-6. Lancet 1989;1:730.
16. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature 1993;362:458-62.
17. Black JB, Sanderlin KC, Goldsmith CS, Gary HE, Lopez C, Pellett PE. Growth properties of human herpesvirus-6 strain Z29. J Virol Methods 1989;26:133-45.
18. Frenkel N, Schirmer EC, Katsafanas G, June CH. T-cell activation is required for efficient replication of human herpesvirus 6. J Virol 1990;64:4598-602.
19. Yadav M, Umamaheswari S, Ablashi DV. Low prevalence of antibody to human herpesvirus-6 (HHV-6) in Kadazans. Southeast Asian J Trop Med Public Health 1990;21:259-63.
20. Farr TJ, Harnett GB, Pietroboni GR, Bucens MR. The distribution of antibodies to HHV-6 compared with other herpesviruses in young children. Epidemiol Infect 1990;105: 603-7.
21. Yoshikawa T, Suga S, Asano Y, Yazaki T, Kodama H, Ozaki T. Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals. Pediatrics 1989;84:675-7.
22. Knowles WA, Gardner SD. High prevalence of antibody to human herpesvirus-6 and seroconversion associated with rash in two infants. Lancet 1988;2:912-13.
23. Leach CT, Sumaya CV, Brown NA. Human herpesvirus-6: clinical implications of a recently discovered, ubiquitous agent. J Pediatr 1992;121:173-81.
24. Brown NA, Sumaya CV, Liu CR, et al. Fall in human herpesvirus 6 seropositivity with age. Lancet 1988;2:396.
25. Ranger S, Patillaud S, Denis F, et al. Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world. J Med Virol 1991;34:194-8.
26. Fox JD, Briggs M, Ward PA, Tedder RS. Human herpesvirus 6 in salivary glands. Lancet 1990;336:590-3.
27. Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet 1990;335:1598-9.
28. Harnett GB, Farr TJ, Pietroboni GR, Bucens MR. Frequent shedding of human herpesvirus 6 in saliva. J Med Virol 1990;30:128-30.
29. Krueger GRF, Wassermann K, DeClerck LS, et al. Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990;336:1255-6.
30. Levy JA, Greenspan D, Ferro F, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-50.
31. Cone RW, Huang ML, Ashley R, Corey L. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1993;31:1262-7.
32. Takahashi K, Sonoda S, Kawakami K, et al. Human herpesvirus 6 and exanthem subitum. Lancet 1988;1:1463.
33. Leach CT, Newton ER, McParlin S, Jenson HB. Human herpesvirus 6 infection of the female genital tract. J Infect Dis 1994;169:1281-3.
34. Okuno T, Oishi H, Hayashi K, Nonogaki M, Tanaka K, Yamanishi K. Human herpesviruses 6 and 7 in cervixes of pregnant women. J Clin Microbiol 1995;33:1968-70.
35. Aubin JT, Poirel L, Agut H, et al. Intrauterine transmission of human herpesvirus 6. Lancet 1992;340:482-3.
36. Ando Y, Kakimoto K, Ekuni Y, Ichijo M. HHV-6 infection during pregnancy and spontaneous abortion. Lancet 1992; 340:1289.
37. Dunne WM Jr, Demmler GJ. Serological evidence for congenital transmission of human herpesvirus 6. Lancet 1992; 340:121-2.
38. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med 1994;331:432-8.
39. Wiersbitzky S, Beyersdorf E, Burtzlaff C, Wiersbitzky H, Crusius S, Weinke I. Pre- and perinatal infections due to human herpesvirus-6 and Epstein-Barr virus with lethal outcome or severe residual encephalopathy. Padiatr Grenzgeb 1993;31:199-201.
40. Mendel I, de Matteis M, Bertin C, et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995;14:993-7.
41. Yoshikawa T, Nakashima T, Asano Y, et al. Endonuclease analyses of DNA of human herpesvirus-6 isolated from blood before and after bone marrow transplantation. J Med Virol 1992;37:228-31.
42. Cuende JI, Ruiz J, Civeira MP, Prieto J. High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of health individuals detected by nested-PCR. J Med Virol 1994;43: 115-8.
43. Jarrett RF, Clark DA, Josephs SF, Onions DE. Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol 1990;32:72-6.
44. Levine PH, Jahan N, Murari P, Manak M, Jaffe ES. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992;166:291-5.
45. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-4.
46. Ueda K, Kusuhara K, Hirose M, et al. Exanthem subitum and antibody to human herpesvirus-6. J Infect Dis 1989;159: 750-2.
47. Yoshiyama H, Suzuki E, Yoshida T, Kajii T, Yamamoto N. Role of human herpesvirus 6 infection in infants with exanthema subitum. Pediatr Infect Dis J 1990;9:71-4.
48. Berenberg W, Wright S, Janeway CA. Roseola infantum (exanthem subitum). N Engl J Med 1949;241:253-9.
49. Kempe CH, Shaw EB, Jackson JR, Silver HK. Studies on the etiology of exanthema subitum (roseola infantum). J Pediatr 1950;37:561-8.
50. Hellstrom B, Vahlquist B. Experimental inoculation of roseola infantum. Acta Paediatr 1951;40:189-97.
51. Dewhurst S, McIntyre K, Schnabel K, Hall CB. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of US infants. J Clin Microbiol 1993;31:416-8.
52. Dewhurst S, Chandran B, McIntyre K, Schnabel K, Hall CB. Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology 1992;190:490-3.
53. Okada K, Ueda K, Kusuhara K, et al. Exanthema subitum and human herpesvirus 6 infection: clinical observations in fifty-seven cases. Pediatr Infect Dis J 1993;12:204-8.
54. Asano Y, Yoshikawa T, Suga S, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 1994;93: 104-8.
55. Kusuhara K, Ueda K, Miyazaki C, Okada K, Tokugawa K. Attack rate of exanthem subitum in Japan. Lancet 1992; 340:482.
56. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992;326:1445-50.
57. Segondy M, Astruc J, Atoui N, Echenne B, Robert C, Agut H. Herpesvirus 6 infection in young children. N Engl J Med 1992;327:1099-100.
58. Portolani M, Cermelli C, Moroni A, et al. Human herpesvirus-6 infections in infants admitted to hospital. J Med Virol 1993;39:146-51.
59. Asano Y, Suga S, Yoshikawa T, Urisu A, Yazaki T. Human herpesvirus type 6 infection (exanthem subitum) without fever. J Pediatr 1989;115:264-5.
60. Suga S, Yoshikawa T, Asano Y, Yazaki T, Hirata S. Human herpesvirus-6 infection (exanthem subitum) without rash. Pediatrics 1989;83:1003-6.
61. Kawaguchi S, Suga S, Kozawa T, Nakashima T, Yoshikawa T, Asano Y. Primary human herpesvirus-6 infection (exanthem subitum) in the newborn. Pediatrics 1992;90:628-30.
62. Asano Y, Nakashima T, Yoshikawa T, Suga S, Yazaki T. Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 1991;118: 891-5.
63. Asano Y, Yoshikawa T, Kajita Y, et al. Fatal encephalitis/ encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992;67:1484-5.
64. Huang LM, Lee CY, Lee PI, Chen JM, Wang PJ. Meningitis caused by human herpesvirus-6. Arch Dis Child 1991;66: 1443-4.
65. Ishiguro N, Yamada S, Takahashi T, et al. Meningoencephalitis associated with HHV-6 related exanthem subitum. Acta Paediatr Scand 1990;79:987-9.
66. McCullers JA, Lakeman FD, Whitley RJ. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis 1995;21:571-6.
67. Kondo K, Nagafuji H, Hata A, Tomomori C, Yamanishi K. Association of human herpesvirus 6 infection of the central nervous system with recurrence of febrile convulsions. J Infect Dis 1993;167:1197-200.
68. Suga S, Yoshikawa T, Asano Y, et al. Clinical and virological analyses of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann Neurol 1993;33:597-603.
69. Ward KN, Gray JJ. Primary human herpesvirus-6 infection is frequently overlooked as a cause of febrile fits in young children. J Med Virol 1994;42:119-23.
70. Yoshikawa T, Nakashima T, Suga S, et al. Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. Pediatrics 1992;89:888-90.
71. Caserta MT, Hall CB, Schnabel K, et al. Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 1994;170:1586-9.
72. Jee SH, Long CE, Schnabel KC, Sehgal N, Epstein LG, Hall CB. Risk of recurrent seizures after a primary human herpesvirus 6-induced febrile seizure. Pediatr Infect Dis J 1998;17:00-00.
73. Niederman JC, Liu CR, Kaplan MH, Brown NA. Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet 1988;2:817-8.
74. Stettner-Gloning R, Jager G, Gloning H, Pontz BF, Emmrich P. Lymphadenopathy in connection with human herpes virus type 6 (HHV-6) infection. Clin Invest 1992;70:59-62.
75. Akashi K, Eizuru Y, Sumiyoshi Y, et al. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993;329:168-71.
76. Steeper TA, Horwitz CA, Ablashi DV, et al. The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol 1990;93:776-83.
77. Dubedat S, Kappagoda N. Hepatitis due to human herpesvirus-6. Lancet 1989;2:1463-4.
78. Sobue R, Miyazaki H, Okamoto M, et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 1991;324:1290.
79. Levine PH, Jahan N, Murari P, Manak M, Jaffe ES. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992;166:291-5.
80. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Johnson RW. Human herpesvirus 6 infection in renal-transplant recipients. N Engl J Med 1989;320:1560-1.
81. Gudnason T, Dunn DL, Brown NA, Balfour HH. Human herpes virus 6 infections in hospitalized renal transplant recipients. Clin Transpl 1991;5:359-64.
82. Asano Y, Yoshikawa T, Suga S, et al. Human herpesvirus 6 harbouring in kidney. Lancet 1989;2:1391.
83. Yoshikawa T, Suga S, Asano Y, et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 1992;54:879-83.
84. Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990;49: 519-22.
85. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992;165:925-9.
86. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991;78: 1381-4.
87. Asano Y, Yoshikawa T, Suga S, et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 1991;324:634-5.
88. Michel D, Muller S, Worz S, et al. Human herpesvirus 6 DNA in exanthematous skin in BMT patient. Lancet 1994; 344:686.
89. Frenkel N, Katsafanas GC, Wyatt LS, Yoshikawa T, Asano Y. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6. Bone Marrow Transplant 1994;14: 839-43.
90. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
91. Carrigan DR, Knox KK. Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-10.
92. Knox KK, Carrigan DR. Chronic myelosuppression associated with persistent bone marrow infection due to human herpesvirus 6 in a bone marrow transplant recipient. Clin Infect Dis 1996;22:174-5.
93. Rosenfeld CS, Rybka WB, Weinbaum D, et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995;23: 626-9.
94. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991;338:147-9.
95. Pitalia AK, Liu-Yin JA, Freemont AJ, Morris DJ, Fitzmaurice RJ. Immunohistological detection of human herpes virus 6 in formalin-fixed, paraffin-embedded lung tissues. J Med Virol 1993;41:103-7.
96. Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993;329:156-61.
97. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994;330:1356-60.
98. Ward KN, Gray JJ, Efstathiou S. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989;28:69-72.
99. Sutherland S, Christofinis G, O'Grady J, Williams R. A serological investigation of human herpesvirus 6 infections in liver transplant recipients and the detection of cross-reacting antibodies to cytomegalovirus. J Med Virol 1991; 33:172-6.
100. Singh N, Carrigan DR, Gayowski T, Singh J, Marino IR. Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient. Transplantation 1995;60:1355-7.
101. Luppi M, Barozzi P, Maiorana A, Marasca R, Torelli G. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994;169:943-4.
102. Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993;56:917-9.
103. Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994;49: 213-4.
104. Liedtke W, Malessa R, Faustmann PM, Eis-Hübinger AM. Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis. J Neurovirol 1995;1: 253-8.
105. + T lymphocytes by HIV-1 and HHV-6. Nature 1989;337:370-3.
106. + T lymphocytes by human herpesvirus 6. Nature 1991;349:533-5.
107. Schonnebeck M, Krueger GR, Braun M, et al. Human herpesvirus-6 infection may predispose cells to superinfection by other viruses. In Vivo 1991;5:255-63.
108. Ensoli B, Lusso P, Schachter F, et al. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J 1989;8: 3019-27.
109. Di Luca D, Secchiero P, Bovenzi P, et al. Reciprocal in vitro interactions between human herpesvirus-6 and HIV-1 Tat. AIDS 1991;5:1095-8.
110. Horvat RT, Wood C, Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol 1989;63:970-3.
111. Horvat RT, Wood C, Josephs SF, Balachandran N. Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments. J Virol 1991;65: 2895-902.
112. Martin ME, Nicholas J, Thomson BJ, Newman C, Honess RW. Identification of a transactivating function mapping to the putative immediate-early locus of human herpesvirus 6. J Virol 1991;65:5381-90.
113. Geng YQ, Chandran B, Josephs SF, Wood C. Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter. J Virol 1992;66:1564-70.
114. Kashanchi F, Thompson J, Sadaie MR, et al. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6. Virology 1994;201:95-106.
115. Nicholas J, Martin ME. Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J Virol 1994; 68:597-610.
116. Thompson J, Choudhury S, Kashanchi F, et al. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 1994;9:1167-75.
117. Thomson BJ, Weindler FW, Gray D, Schwaab V, Heilbronn R. Human herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expression. Virology 1994;204: 304-11.
118. Wang J, Jones C, Norcross M, Bohnlein E, Razzaque A. Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner. J Virol 1994;68:1706-13.
119. Zhou Y, Chang CK, Qian G, Chandran B, Wood C. transactivation of the HIV promoter by a cDNA and its genomic clones of human herpesvirus-6. Virology 1994;199:311-22.
120. Chen H, Pesce AM, Carbonari M, et al. Absence of antibodies to human herpesvirus-6 in patients with slowly-progressive human immunodeficiency virus type 1 infection. Eur J Epidemiol 1992;8:217-21.
121. Madea B, Roewert HJ, Krueger GR, Ablashi DV, Josephs SF. Search for early lesions following human immunodeficiency virus type 1 infection: a study of six individuals who died a violent death after seroconversion. Arch Pathol Lab Med 1990;114:379-82.
122. Corbellino M, Lusso P, Gallo RC, Parravicini C, Galli M, Moroni M. Disseminated human herpesvirus 6 infection in AIDS. Lancet 1993;342:1242.
123. Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet 1994;343:577-8.
124. Clark DA, Ait-Khaled M, Wheeler AC, et al. Quantification of human herpesvirus 6 in immunocompetent persons and post-mortem tissues from AIDS patients by PCR. J Gen Virol 1996;77:2271-5.
125. Brown NA, Kovacs A, Lui CR, Hur C, Zaia JA, Mosley JW. Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet 1988;2:1146.
126. Essers S, Schwinn A, ter Meulen J, et al. Seroepidemiological correlations of antibodies to human herpesviruses and human immunodeficiency virus type 1 in African patients. Eur J Epidemiol 1991;7:658-64, 1991.
127. Fox J, Briggs M, Tedder RS. Antibody to human herpesvirus 6 in HIV-1 positive and negative homosexual men. Lancet 1988;2:396-7.
128. Spira TJ, Bozeman LH, Sanderlin KC, et al. Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis 1990;161:567-70.
129. Gautheret A, Aubin JT, Fauveau V, Rozenbaum W, Huraux JM, Agut H. Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Clin Microbiol Infect Dis 1995;14:820-4.
130. Nigro G, Luzi G, Krzysztofiak A, D'Orio F, Aiuti F. Detection of IgM antibodies to human herpesvirus 6 in Romanian children with nonprogressive human immunodeficiency virus disease. Pediatr Infect Dis J 1995;14:891-94.
131. Fox JD, Ward P, Briggs M, Irving W, Stammers TG, Tedder RS. Production of IgM antibody to HHV6 in reactivation and primary infection. Epidemiol Infect 1990;104:289-96.
132. Suga S, Yoshikawa T, Asano Y, et al. IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 1992;36:495-506.
133. Huang LM, Kuo PF, Lee CY, Chen JY, Liu MY, Yang CS. Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma. J Med Virol 1992;38:7-10.
134. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-80.
135. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996;88:3615-20.
136. Agut H, Collandre H, Aubin JT, et al. In vitro sensitivity of human herpesvirus-6 to antiviral drugs. Res Virol 1989;140: 219-28.
137. Agut H, Huraux JM, Collandre H, Montagnier L. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet 1989;2:626.
138. Russler SK, Tapper MA, Garrigan DR. Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet 1989;2:382.
139. Burns WH, Sandford GR. Susceptibility of human herpesvirus 6 to antivirals in vitro. J Infect Dis 1990;162:634-7.
140. Takahashi K, Suzuki M, Iwata Y, Shigeta S, Yamanishi K, DeClercq E. Selective activity of various nucleoside and nucleotide analogues against human herpesvirus 6 and 7. Antivir Chem Chemother 1997;8:24-31.
141. Torigoe S, Kumamoto T, Koide W, Taya K, Yamanishi K. Clinical manifestations associated with human herpesvirus 7 infection. Arch Dis Child 1995;72:518-9.
142. Secchiero P, Berneman ZN, Gallo RC, Lusso P. Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. Virology 1994;202:506-12.
143. Wilborn F, Schmidt CA, Lorenz F, et al. Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction. J Med Virol 1995;47:65-9.
144. Di Luca D, Mirandola P, Ravaioli T, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995;45:462-8.
145. Kidd IM, Clark DA, Ait-Khaled M, Griffiths PD, Emery VC. Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction. J Infect Dis 1996;174:396-401.
146. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T, Yamanishi K. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J Pediatr 1994;125:1-5.
147. Hidaka Y, Okada K, Kusuhara K, Miyazaki C, Tokugawa K, Ueda K. Exanthem subitum and human herpesvirus 7 infection. Pediatr Infect Dis J 1994;13:1010-11.
148. Ueda K, Kusuhara K, Okada K, et al. Primary human herpesvirus 7 infection and exanthema subitum. Pediatr Infect Dis J 1994;13:167-8.
149. Asano Y, Suga S, Yoshikawa T, Yazaki T, Uchikawa T. Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics 1995;95: 187-90.
150. Caserta M, Hall CB, Schnabel K, D'Heron N. Human herpesvirus-7 (HHV-7) infection in US children [Abstract 996]. Pediatr Res 1996;39:168A.
151. Kawa-Ha K, Tanaka K, Inoue M, et al. Isolation of human herpesvirus 7 from a child with symptoms mimicking chronic Epstein-Barr virus infection. Br J Haematol 1993; 84:545-8.